Asterias Biotherapeutics, Inc. (AST)

[DeepDive]

Very very very good prelim efficacy news on OPC1.

Can't wait to see results on 20 mill cells.

This is nothing short of revolutionary for medicine.

I love it that the board is deserted. This little gem is undiscovered.

We saw that the Co estimated the TAM at 2bill. Pa, no competition. This is a 10 billion m. Cap on this indication alone.


Then, there are all the future uses of nerve cells in brain related issues.

The opportunity is SO LARGE it boggles the mind.

Still, the better position, risk adjusted is BTX the mother ship.